| Literature DB >> 34221195 |
Cláudia B Santos-Pinto1, Claudia S Osorio-De-Castro2, Larissa M Ferreira3, Elaine S Miranda4.
Abstract
BACKGROUND: Zika virus (ZIKV) infection emerged in Brazil in 2015, leading to the declaration of a national public health emergency, mainly due to its consequences for pregnant women and newborn babies. The Zika epidemic demanded major efforts from the public health system to address the full range of disease consequences.Entities:
Keywords: Brazil; Counseling; Epidemics; Infant; Pharmaceutical Services; Pharmacists; Pregnant Women; Primary Health Care; Professional Role; Public Health; Qualitative Research; Zika Virus; Zika Virus Infection
Year: 2021 PMID: 34221195 PMCID: PMC8234616 DOI: 10.18549/PharmPract.2021.2.2290
Source DB: PubMed Journal: Pharm Pract (Granada) ISSN: 1885-642X
Knowledge of ZIKV disease reported by the respondents (N=42)
| Subcategory | N | % |
|---|---|---|
| Transmission | ||
| Reported that Aedes is the vector | 41 | 97.6 |
| Intrauterine transmission | 10 | 23.8 |
| Transmission through blood and semen | 3 | 7.1 |
| Signs and symptoms | ||
| Correctly reported at least 3 symptoms | 3 | 7.1 |
| Correctly reported 2 symptoms | 11 | 26.1 |
| Correctly reported 1 symptom | 8 | 19.0 |
| Admitted not being aware of the symptoms | 2 | 4.7 |
| Cases can be asymptomatic | 2 | 4.7 |
| Gave incorrect information about the symptoms | 10 | 23.8 |
| Diagnosis | ||
| Didn’t know how diagnosis is performed | 36 | 85.7 |
| Gave incorrect/imprecise information about diagnosis | 4 | 9.5 |
| Had knowledge about laboratory testing approach | 2 | 4.7 |
| Consequences | ||
| Microcephaly and fetal malformation | 19 | 45.2 |
| Acute neurological syndrome | 2 | 4.7 |
Knowledge about prevention, surveillance, communication and information measures reported by the respondents (N=42)
| Subcategory | N | % |
|---|---|---|
| Individual protection | ||
| Avoid contact with the vector | 35 | 83.3 |
| Condom use | 1 | 2.3 |
| Special precautions for pregnant women | 1 | 2.3 |
| Collective protection | ||
| Vector combat (insecticides, larvicides) | 32 | 76.1 |
| Avoid standing water | 14 | 33.3 |
| Keep surroundings clean | 6 | 14.2 |
| Prevention measures related to health services | ||
| Home visits from endemic disease control agents | 16 | 38.0 |
| Distribution of repellent for pregnant women under
the | 6 | 14.2 |
| Prevention campaigns in health facilities with distribution of material | 2 | 4.7 |
| General counseling in health facilities | 1 | 2.3 |
| The role of epidemiological surveillance | ||
| Identification and follow-up of new cases | 13 | 30.9 |
| Notification | 8 | 19.0 |
| Vector prevention and combat campaigns | 6 | 14.2 |
| Informs decision-making | 3 | 7.1 |
| Didn’t know | 18 | 42.8 |
| Incorrect response | 3 | 7.1 |
| Notification | ||
| Reported being aware of the notification process | 5 | 11.9 |
| Reported not being aware of the notification process | 37 | 88.0 |
| Health information and communication measures | ||
| Dissemination of information by TV | 8 | 19.0 |
| Vector control bulletins | 1 | 2.3 |
| Breeding ground elimination campaigns | 1 | 2.3 |
Information provided to the public by the respondents (N=42)
| Subcategory | N | % |
|---|---|---|
| To the general public | ||
| Notification and elimination of breeding grounds | 41 | 97.6 |
| Use of repellent | 29 | 69.0 |
| Domestic health measures | 15 | 35.7 |
| Seeking health services | 7 | 16.6 |
| Use of mosquito nets | 4 | 9.5 |
| Use of protective clothing | 4 | 9.5 |
| Use of over-the-counter medicines | 4 | 9.5 |
| Importance of hydration | 2 | 4.7 |
| Warning against self-medication | 2 | 4.7 |
| To pregnant women | ||
| Individual prevention measures | 42 | 100 |
| Prevention measures in the surroundings | 42 | 100 |
| Advice on precautions and seeking services | 18 | 42.8 |
| Information about ZIKV disease | 6 | 14.2 |
| Contraceptive measures | 3 | 7.1 |
| Risks to the fetus | 1 | 2.3 |
Treatment recommendations mentioned by the respondents (N=42)
| Recommendations (subcategory) | N | % |
|---|---|---|
| Complete (analgesics, antipyretics, hydration, antihistamines, situations where NSAIDs and ASA should be avoided) | 0 | 0 |
| Incomplete (mentioned at least 1 of the above recommendations) | 29 | 69.0 |
| Incorrect (at least one incorrect recommendation) | 4 | 9.5 |
| Was aware of the treatment recommendations | 8 | 19.0 |
| Didn’t want to answer | 1 | 2.3 |
| Total | 42 | 100.0 |